Han Manman
Suzhou Hospital Affiliated To Anhui Medical University, No. 299 Bianhe Middle Road, Suzhou, AnHui 234000, China.
J Diabetes Res. 2020 Aug 24;2020:1032049. doi: 10.1155/2020/1032049. eCollection 2020.
The objective of this review was to provide a summary of the literature on the dose-response relationship between alcohol consumption and risk of type 2 diabetes (T2D) in Asian populations, particularly men. The present study was recorded in PROSPERO as CRD 42019121073. We searched the PubMed-Medline, Web of Science, and Cochrane Library for studies published in any language since the database inception to January 2019. Prospective cohort studies were included in the meta-analysis. Relative risks (RRs) and 95% confidence intervals (CIs) were calculated for random-effects models and dose-response meta-analyses. In total, 8 prospective cohort studies were included. High alcohol intake was significantly associated with increased risk of T2D (RR = 1.16, 95% CI: 1.04-1.29; Q statistic = 0.326) compared to the lowest category of alcohol intake. Nonlinear association was observed between alcohol consumption and T2D risk in men ( = 0.003). Dose-wise, consuming ≤57 g/day of alcohol was not associated with the risk of T2D in this study; however, alcohol intake >57 g/day was associated with increased risk of T2D in men. Overall, the association between alcohol consumption and T2D among Asian men was J-shaped. Lifestyle recommendations for prevention of T2D should include advice on limiting alcohol intake. This trial is registered with Prospero registration: CRD 42019121073.
本综述的目的是总结关于亚洲人群,尤其是男性,饮酒量与2型糖尿病(T2D)风险之间剂量反应关系的文献。本研究已在国际前瞻性系统评价注册库(PROSPERO)中注册,注册号为CRD 42019121073。我们检索了PubMed-Medline、科学网和考克兰图书馆,查找自数据库建立至2019年1月期间以任何语言发表的研究。纳入荟萃分析的为前瞻性队列研究。计算随机效应模型和剂量反应荟萃分析的相对风险(RRs)及95%置信区间(CIs)。总共纳入了8项前瞻性队列研究。与最低饮酒量类别相比,高酒精摄入量与T2D风险增加显著相关(RR = 1.16,95% CI:1.04 - 1.29;Q统计量 = 0.326)。在男性中,观察到饮酒量与T2D风险之间存在非线性关联( = 0.003)。按剂量来看,本研究中每天饮酒量≤57克与T2D风险无关;然而,男性每天饮酒量>57克与T2D风险增加相关。总体而言,亚洲男性饮酒量与T2D之间的关联呈J形。预防T2D的生活方式建议应包括限制酒精摄入量的建议。本试验已在国际前瞻性系统评价注册库注册:CRD 42019121073。